In a world where cancer remains a leading cause of death, we are convinced that only advances in research will cure cancer! This is why we have placed research at the heart of our mission: research on cancer and for individuals, dynamic and positive research, accessible to as many people as possible.
While the challenges remain numerous, our daily mission is to outline the strategic directions of cancer research, support today's most innovative initiatives for tomorrow, accelerate the most promising projects, identify, unite, and promote the best talent, and share with everyone the knowledge that allows us to be better equipped to fight the disease.
It is thanks to the discoveries of scientists, driven by a surge of solidarity from donors to researchers, for patients, that today we contribute to curing approximately 60% of cancers. Tomorrow, we hope we will finally achieve victory: one day curing cancer, all cancers.
The Company of Biologists is a not-for-profit publishing organisation dedicated to supporting and inspiring the biological community. We are run by distinguished practising scientists. We exist to profit science, not shareholders. We inspire new thinking and support the community of biologists. The focus of our activities is: (i) publishing leading peer-reviewed journals; (ii) facilitating scientific meetings and communities; (iii) providing travel grants for young researchers; (iv) supporting and funding research societies.
Auvergne-Rhône-Alpes is a region which was created following the merge between Auvergne and Rhône-Alpes. It consists of 12 departments and one territorial collectivity (Lyon Métropole), regrouping a population of 8 163 884 inhabitants in 2022.
The CIRI (Centre International de Recherche en Infectiologie) brings together the scientific and medical research communities in infectious diseases and immunity in the Lyon-St Etienne area, with the University of Lyon 1, Inserm, CNRS and ENS de Lyon as main managing bodies, and Hospices Civils de Lyon and Université Jean Monnet as secondary managing bodies, and important partnerships with VetAgroSup and Institut Pasteur. More than 400 researchers with complementary disciplinary backgrounds are grouped into 3 main departments: immunologists, bacteriologists and virologists, some of them being as well as cancerologists and epidemiologists. They work together with the main objective of understanding the biology of microbes and the immune system, and the interactions between microbes and their hosts, in order to better combat infectious diseases and other illnesses involving the immune system.
The overarching scientific program that ties our teams revolves around the study of the physiopathology of the neuron and the skeletal muscle. We aim at deciphering basic biological mechanisms at the molecular, cell, tissue and organism levels to better understand their alterations in human pathologies to uncover new therapeutic approaches. To reach that goal, our teams combine multiscale, multidisciplinary approaches, taking advantage of the most appropriate models to conduct an ambitious research around three main research axes: (1) Physiology and cell biology of the neuromuscular system, (2) Cellular and molecular neurobiology and (3) Nuclear dynamics.
Because the fields of interests of the different teams are tightly intermingled, the unit fosters active collaborations between the teams and our laboratory is an asset to tackle scientific and medical issues that are crucial for our understanding of the biology of the nervous and muscular systems.
Bio-Techne is headquartered in Minneapolis, Minnesota and employs over 3,000 people globally at 34 locations worldwide. As a global developer, manufacturer and supplier of high-quality reagents, analytical instruments and precision diagnostics, Bio-Techne has an extensive catalog of over 500,000 products.
Incorporated in 1981 as R&D Systems, the company changed its name to Bio-Techne in 2014. Our growth has been accelerated through acquisitions, organic investments, diversification of our customer base and expansion into new markets. In fiscal year 2023, Bio-Techne delivered net sales of over $1.1 billion.
Bio-Techne includes the following brands: ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems and Tocris Bioscience.
At Charles River, we’re dedicated to helping you accelerate research and drug development—because every moment matters. Our essential products and services empower pharmaceutical, biotech, government, and academic teams to turn possibilities into breakthroughs. From discovery to early development and safe manufacturing, we provide the solutions you need to bring new therapies to patients faster.
InvivoGen was founded in 1997 by scientists with technical expertise and creative excellence stemming from a longstanding history in microbiology. InvivoGen's unparalleled skill in microbial fermentation enables us to provide a wide range of biological molecules, including ultra-pure antibiotics, novel mycoplasma treatments and the largest collection of pattern recognition receptor agonists derived from a wide range of micro-organisms.
In addition we boast strong chemistry and molecular biology teams for the synthesis of molecules and plasmids for research use and studies focused on gene therapy and vaccination. Moreover, our specialized study of the innate immune receptor signaling pathways has resulted in the collection of reporter cell lines, which are routinely used for in-house quality control and research and development.
Our mission is to advance scientific understanding and medicine by providing solutions for cell and gene therapy and biomedical research. We believe in biomedical science as the strongest driver to change the way we treat cancer, autoimmune diseases, and neurodegenerative disorders. The design of therapeutics is evolving away from chemistry-based science towards individual treatments that focus on cell-based approaches and more targeted drugs. We are driving the revolution that is reinventing medicine and advancing it to a level that will make cancer and other serious diseases history.
Proteintech is an antibody manufacturer selling directly to scientists and only selling its own products to maintain the highest level of quality control leading to superior reproducibility and lot consistency. With over 2/3 target coverage of proteins encoded by the human genome, Proteintech’s 12,000+ antibodies are used every day by scientists all over the world in a wide spectrum of research areas.
At Sartorius, we empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine.
We are a magnet and dynamic platform for pioneers and leading experts in our field. We bring creative minds together for a common goal: technological breakthroughs that lead to better health for more people.
STEMCELL Technologies provides high-quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources to scientists around the world working on stem cell, immunology, cancer, regenerative medicine, and cellular therapy research. At STEMCELL, we are dedicated to improving lives through advanced knowledge and scientific discovery, through our commitment to fostering diversity and inclusion in STEM and the life sciences industry, and through our investments in sustainability, community, and social responsibility. Rooted in scientific expertise and rigor, we are a company of Scientists Helping Scientists, and we care deeply about making the world a better place.
We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster.
With Tebubio, you can concentrate your efforts and accelerate what’s most important to you: Your Research.
Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy.
We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, we have received growing customer testimonials and numerous citations in high-impact publications.
Operating as a multinational company with branches in North America, Europe, China, Japan, South Korea, Australia and Israel, VectorBuilder has served customers in over 90 countries and collaborated with thousands of organizations around the world, including universities, research institutions, biotech/pharma companies, and governmental agencies.
Loading... 
